Skip to main content
Mercury Laboratories Limited logo

Mercury Laboratories Limited — Investor Relations & Filings

Ticker · 538964 ISIN · INE947G01011 LEI · 98450068F40047C86C71 BSE.NS Manufacturing
Open in API
Filings indexed 410 across all filing types
Latest filing 2026-05-23 Regulatory Filings
Country IN India
Listing BSE.NS 538964

About Mercury Laboratories Limited

https://mercurylabs.com/

Mercury Laboratories Limited specializes in the development, manufacturing, and marketing of a diverse range of pharmaceutical formulations. Established in 1962, the company focuses on therapeutic segments including gynecology, pediatrics, cardiology, and orthopedics. Its product portfolio encompasses various dosage forms such as tablets, capsules, liquid orals, and injectables. The company operates WHO-GMP certified manufacturing facilities, ensuring adherence to international quality standards. Mercury Laboratories maintains a significant presence in both domestic and international markets, providing healthcare solutions through a robust distribution network. Key products include specialized treatments for maternal health and pediatric care, alongside general medicine offerings.

Recent filings

Filing Released Lang Actions
Mercury Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve the Audited Financial ....
Regulatory Filings Classification · 90% confidence The document is a formal SEBI LODR disclosure to the stock exchange notifying of an upcoming Board meeting to consider and approve the audited financial results. It contains no actual financial data or results, nor any attachments of reports. It is a regulatory announcement (notice) rather than the report itself or a specific earnings release. This falls under the general Regulatory Filings category.
2026-05-23 English
Intimation of Newspaper advertisement regarding notice of transfer of shares to IEPFA and special window for dematerialization of physical transfer
Regulatory Filings Classification · 87% confidence The document is a compliance filing under SEBI LODR Regulation 47 announcing the submission of a newspaper advertisement regarding unclaimed dividends/transfer of shares to the IEPF and a special dematerialization window. It contains no financial data, meeting notices, or voting matters; rather, it is a routine regulatory announcement. It does not match specific categories like dividend notices (DIV), share issues (SHA), or report publications (RPA), so it defaults to a general regulatory filing (RNS).
2026-05-08 English
Intimation to shareholder relating to transfer of Equity shares to IEPFA is attached
Regulatory Filings Classification · 80% confidence The document is an SEBI LODR Regulation 30 intimation to BSE and shareholders regarding the transfer of unclaimed dividend shares to the IEPF Authority. It is a regulatory compliance announcement rather than a financial report, earnings release, dividend declaration, or meeting material. It does not fit categories like DIV (dividend amount notice) which covers dividend payment announcements, nor any other specific category. As a general regulatory filing and compliance update, it best fits into Regulatory Filings (RNS).
2026-05-07 English
Format of the Annual Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars ....
Regulatory Filings
2026-04-29 English
Intimation of Resignation of SM Plant head jarod attched
Regulatory Filings
2026-04-29 English
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details ....
Regulatory Filings
2026-04-29 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.